Elena Roy
Head of Product Safety at TiGenix | Greater Madrid Metropolitan Area, Spain
Elena Roy’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Head of Product Safety at TiGenix in August 2016 - Present
Pharmacovigilance Manager - Product Safety Manager at Mabxience in December 2014 - August 2016
Pharmacovigilance Physician - Sr PHARMACOVIGILANCE MANAGER - QPPV- BACK-UP at PharmaMar in April 2007 - December 2014
Medical Director at Dynamic Solutions in March 2005 - July 2007
Clinical Research Deputy Director - Medical Writer at MDS Pharma Services in October 1999 - March 2005
Local Clinical Operations Manager at Roche in September 1997 - September 1999
CNS Medical Adviser at Synthelabo in July 1994 - August 1997
Clinical Trials Monitor at Abbott in April 1993 - July 1994
Pharmacovigilance Responsible / Phase II-IIIb Clinical Trials Responsible at Roussel Ibérica (Hoechst Marion Roussel Inc.) in April 1990 - April 1993
General Practice and Paediatrics Practitioner at Spanish National Health Service INSALUD- Private Practitioner (URCLISA CENTER) in January 1980 - January 1990
Chemotherapy Foundation, Oncology
Royal College of Pharmacy, Madrid, Lecturer on Royal College of Pharmacy
National Health School (Ministry of Health) Madrid, Paediatrician Diploma Holder
TiGenix NV (Euronext Brussels and Nasdaq: TIG) is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic, or donor-derived, expanded stem cells. Considered to be the most advanced stem cell company in the world, with lead product candidate Cx601 having reported positive phase III results and long-term efficacy. Cx601 is being developed for complex perianal fistulas, which is a complication of Crohn’s Disease. Cx601 has been granted Orphan Drug status in Europe and expects to receive its European marketing authorization by year-end 2017. TiGenix has an exclusive licensing agreement with Takeda, a large pharmaceutical company active in gastroenterology, under which Takeda maintains the exclusive right to commercialize Cx601 for complex perianal fistulas outside the United States. TiGenix is headquartered in Leuven (Belgium) and has operations in Madrid (Spain). For more information, please visit www.tigenix.com.
Discover more about TiGenix
Executive Assistant bij TiGenix
Executive Assistant at TiGenix
(July 2012 – Present)
Regulatory Affairs Manager en TiGenix
Regulatory Affairs Manager at TiGenix
(Present)
Quality Systems & Compliance Head en Takeda Madrid Cell Therapy Technology Center (TiGenix)
Quality Systems & Compliance Head at TiGenix
(Sep 2019 – Present)
Técnico de control de calidad en TiGenix
Técnico de control de calidad at TiGenix
(May 2017 – Present)
Project Engineer at TiGenix
Project Engineer at TiGenix
(Present)
CMO chez TiGenix
CMO at TiGenix
(Present)
What is Elena Roy email address?
Email Elena Roy at [email protected]. This email is the most updated Elena Roy's email found in 2026.
How to contact Elena Roy?
To contact Elena Roy send an email to [email protected].
What company does Elena Roy work for?
Elena Roy works for TiGenix.
What is Elena Roy's role at TiGenix?
Elena Roy is Head of Product Safety
What industry does Elena Roy work in?
Elena Roy works in the Pharmaceuticals industry.
